Skip to content
Prof. Dr. Mustafa Özdoğan · Medical Oncologist

How Skin Cancers Metastasize Has Been Discovered

How Skin Cancers Metastasize Has Been Discovered

Skin cancers’ metastatic ability has been investigated for some time. In this context, in February 2019, Cell published a study in which the biological mechanism enabling skin cancer cells to metastasize was discovered. This may enable new generations of anti-metastatic treatment.

The research was conducted at King’s College and Queen Mary University in London. It used tumor samples from malignant melanoma patients and melanoma mouse cancer models.

According to the Research Results,

  • The ability of malignant melanoma cells, an aggressive skin cancer type, to metastasize was found to depend largely on Myosin 2 protein. Myosin 2 is involved in cell movement. Increased activity makes cancer cells more mobile and allows rapid spread to other tissues. Myosin 2 also influenced immunity by releasing molecules that program macrophages to assist the tumor . These molecules also change blood vessel structures, enabling cancer cells to migrate to other tissues and organs.
  • Further analyses identified interleukin 1A as the most important of these molecules.
  • Blocking Myosin 2 stopped interleukin 1A release in mouse models and human melanoma tissues.
Regional Activation of Myosin 2 in Cancer Cells Through Crosstalk with the Immune Microenvironment

Figure Explanation: Regional activation of myosin 2 in melanoma cells, through the tumor’s immune microenvironment crosstalk, promotes tumor progression.

What Does This Study Mean for Us?

  • The biological mechanism giving skin cancer invasive/metastatic characteristics was discovered. Myosin 2 plays an important role in this process.
  • Combining Myosin 2 inhibitors with other cancer drugs is being considered. Interleukin 1A inhibitors combined with myosin 2 inhibitors may offer effective cancer treatment. In the near future, clinical trials are planned.
  • Melanoma surgery may leave behind a small number of cells. This study may allow treatments to prevent the spread of these residual cells.

Sources

Mirella Georgouli ve ark.
Regional Activation of Myosin II in Cancer Cells Drives Tumor Progression via a Secretory Cross-Talk with the Immune Microenvironment.
Cell, 31 January 2019.

Appointment request

DROZDOGAN AI

Explore this article together

Ask about the article and read answers alongside published sources from our site.

DROZDOGAN AI

Drozdogan Assistant

How Skin Cancers Metastasize Has Been Discovered

Ask about the article and read answers alongside published sources from our site.

Conversation and privacy information

Drozdogan Assistant answers this conversation. Authorized site administrators may review it for quality. Do not share personal information.

Replies use OpenAI infrastructure. Questions and replies are processed by that service; conversation records are stored on our site. Do not share identifying, contact or personal health information.

0 / 1000

For information only; no personal diagnosis or treatment advice.

Related articles

Explore other articles on this topic.

Stay informed

Receive new articles and scientific updates by email.

Google Analytics runs on public pages independently of this window and may use analytics cookies. Your choice here controls external services only.

Cookie policy